RICC A/S: Financial statements 2016
CVR: 20690003
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
RICC A/S (CVR 20690003) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 134,556,000 and a net result of DKK 66,287,000 compared with DKK 1,229,520,000 the year before. That is a decrease of 22.8% compared with the year before. Equity in the 2016 report amounted to DKK 197,825,000. The solvency ratio was 71.2%. The company had 68 employees in the financial year.
- Gross Profit
- DKK 134,556,000
- Profit/Loss
- DKK 66,287,000
- Equity
- DKK 197,825,000
- Total Assets
- DKK 277,996,000
- Employees
- 68
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 134.6 mio. | 66.3 mio. | 197.8 mio. | 68 |
| 2015 | - | 174.3 mio. | 1.2 mia. | 211.5 mio. | - |
| 2014 | - | 138.2 mio. | -5.5 mio. | -68 mio. | - |
Official annual report
Find more companies like RICC A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
RICC A/S has published its annual report for 2015. Gross profit came to DKK 174,279,000, and the net result was DKK 1,229,520,000.
As of February 1, 2016, Jens Bo Rode Hansen has joined the board of directors of RICC A/S.
As of February 1, 2016, Henrik Ørum has left the board of directors of RICC A/S.
As of February 1, 2016, Jens Bo Rode Hansen is registered as director of RICC A/S.
As of February 1, 2016, Henrik Ørum has stepped down as adm. dir. of RICC A/S.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.